AbbVie Reports Positive Ph1 Results For ABBV-295 Amylin Analog
10 Mar 2026 //
PRESS RELEASE
FDA Expands Label For BMS` Sotyktu To Treat Psoriatic Arthritis
10 Mar 2026 //
FIERCE PHARMA
Roche`s Oral SERD Flunks 1St-Line Breast Cancer Phase 3
10 Mar 2026 //
FIERCE BIOTECH
Kelun-Biotech, Harbour Biomed Get NMPA Nod For SKB575/HBM7575
10 Mar 2026 //
PR NEWSWIRE
Ipsen Withdraws Tazverik In Lymphoma And Sarcoma
10 Mar 2026 //
GLOBENEWSWIRE
Xenon Seeks FDA Approval for Epilepsy Drug After Phase 3 Win
10 Mar 2026 //
BIOSPACE
FDA Proposes to Ease Testing to Speed Up Biosimilar Development
10 Mar 2026 //
REUTERS
Servier Bolsters Brain Cancer Portfolio in $2.5B Day One Deal
07 Mar 2026 //
BIOSPACE
Lonza Shakes Off Capsule Business In $3B Deal With Lone Star
07 Mar 2026 //
FIERCE PHARMA
Drugs In Development
Market Intel

Market Place
Sourcing Support